Vikas Pejaver
Vikas Pejaver
mssm.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Functional and Evolutionary Insights from the Genomes of Three Parasitoid Nasonia Species
JH Werren, S Richards, CA Desjardins, O Niehuis, J Gadau, ...
Science 327 (5963), 343-348, 2010
8102010
REVEL: an ensemble method for predicting the pathogenicity of rare missense variants
NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ...
The American Journal of Human Genetics 99 (4), 877-885, 2016
7112016
The structural and functional signatures of proteins that undergo multiple events of post‐translational modification
V Pejaver, WL Hsu, F Xin, AK Dunker, VN Uversky, P Radivojac
Protein Science 23 (8), 1077-1093, 2014
2532014
Big data in public health: terminology, machine learning, and privacy
SJ Mooney, V Pejaver
Annual review of public health 39, 95-112, 2018
1812018
Inferring the molecular and phenotypic impact of amino acid variants with MutPred2
V Pejaver, J Urresti, J Lugo-Martinez, KA Pagel, GN Lin, HJ Nam, M Mort, ...
Nature communications 11 (1), 1-13, 2020
155*2020
The comparative genomics and complex population history of Papio baboons
J Rogers, M Raveendran, RA Harris, T Mailund, K Leppälä, ...
Science Advances 5 (1), eaau6947, 2019
792019
Missense variant pathogenicity predictors generalize well across a range of function‐specific prediction challenges
V Pejaver, SD Mooney, P Radivojac
Human mutation 38 (9), 1092-1108, 2017
382017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges
R Daneshjou, Y Wang, Y Bromberg, S Bovo, PL Martelli, G Babbi, ...
Human mutation 38 (9), 1182-1192, 2017
332017
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework
G Glusman, PW Rose, A Prlić, J Dougherty, JM Duarte, AS Hoffman, ...
Genome medicine 9 (1), 1-10, 2017
322017
When loss-of-function is loss of function: assessing mutational signatures and impact of loss-of-function genetic variants
KA Pagel, V Pejaver, GN Lin, HJ Nam, M Mort, DN Cooper, J Sebat, ...
Bioinformatics 33 (14), i389-i398, 2017
322017
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results
RP Joshi, V Pejaver, NE Hammarlund, H Sung, SK Lee, A Furmanchuk, ...
Journal of Clinical Virology 129, 104502, 2020
212020
Physicochemical sequence characteristics that influence S-palmitoylation propensity
KD Reddy, J Malipeddi, S DeForte, V Pejaver, P Radivojac, VN Uversky, ...
Journal of Biomolecular Structure and Dynamics 35 (11), 2337-2350, 2017
182017
Research Culture: A survey-based analysis of the academic job market
JD Fernandes, S Sarabipour, CT Smith, NM Niemi, NM Jadavji, AJ Kozik, ...
ELife 9, e54097, 2020
17*2020
The loss and gain of functional amino acid residues is a common mechanism causing human inherited disease
J Lugo-Martinez, V Pejaver, KA Pagel, S Jain, M Mort, DN Cooper, ...
PLoS computational biology 12 (8), e1005091, 2016
122016
Target site specificity and in vivo complexity of the mammalian arginylome
J Wang, VR Pejaver, GP Dann, MY Wolf, M Kellis, Y Huang, BA Garcia, ...
Scientific reports 8 (1), 1-12, 2018
112018
Assessment of methods for predicting the effects of PTEN and TPMT protein variants
V Pejaver, G Babbi, R Casadio, L Folkman, P Katsonis, K Kundu, ...
Human mutation 40 (9), 1495-1506, 2019
102019
Intrinsic size parameters for palmitoylated and carboxyamidomethylated peptides
Z Li, JM Dilger, V Pejaver, D Smiley, RJ Arnold, SD Mooney, ...
International journal of mass spectrometry 368, 6-14, 2014
102014
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
MS Cline, G Babbi, S Bonache, Y Cao, R Casadio, X de la Cruz, O Díez, ...
Human mutation 40 (9), 1546-1556, 2019
92019
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
S Gombar, T Bergquist, V Pejaver, NE Hammarlund, K Murugesan, ...
Diagnostic microbiology and infectious disease 100 (2), 115338, 2021
72021
Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer
A Voskanian, P Katsonis, O Lichtarge, V Pejaver, P Radivojac, ...
Human mutation 40 (9), 1612-1622, 2019
72019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20